Management of Periorbital Hyperpigmentation

Periorbital hyperpigmentation, commonly referred to as dark circles, arises from a combination of increased dermal and epidermal melanin deposition, visible vasculature, volume loss in the tear trough, skin laxity and structural orbital anatomy. Management has evolved from single-modality topical bleaching agents and chemical peels towards a multimodal, algorithmic approach. Contemporary regimens integrate targeted laser and light therapies (including Q-switched and fractional devices), injectable fillers or autologous fat for tear-trough correction, vascular-modulating lasers, intense pulsed light and adjuvant mesotherapeutic or biological injections. Non-invasive imaging and quantitative scales now enable objective classification and monitoring of treatment response. Preventive measures, notably strict photoprotection, underpin long-term maintenance. Personalisation of therapy according to Fitzpatrick skin type, underlying aetiology and patient preference has become central to optimising both safety and efficacy, with increasing attention to minimally invasive techniques that minimise downtime and transient adverse effects. The global burden of periorbital hyperpigmentation has driven research into novel physical modalities and combination protocols designed to address pigmentary, vascular and structural contributors in a single session.

Research from Nature Portfolio

Advanced spectroscopic imaging has been applied to the classification of pigmented dark circles. Using ultrafast pump-probe microscopy, investigators quantitatively mapped melanin granule distribution in excised lower‐eyelid specimens, demonstrating significant differences in melanin content index and fluorescence intensity between pigmented and vascular subtypes. This technique provided high-resolution, label-free discrimination of melanin deposition and holds promise for in vivo subtyping of periorbital hyperpigmentation to guide personalised intervention.

Management of Periorbital Hyperpigmentation publication trend

The graph below shows the total number of articles in management of periorbital hyperpigmentation across all publications each year (not limited to Nature Index journals).

Technical terms

Pump-probe imaging: A laser-based spectroscopic method that employs paired ultrafast pulses to characterise chromophores such as melanin in biological tissues.

Carboxytherapy: Intradermal infusion of carbon dioxide gas to enhance local circulation, oxygenation and subsequent skin tone improvement.

Mesotherapy: Series of microinjections delivering active agents (e.g., tranexamic acid, vitamins) into the superficial dermis to modulate melanogenesis and vascular tone.

Platelet-rich plasma (PRP): Autologous concentration of platelets in plasma enriched with growth factors, used to stimulate tissue remodelling and pigment reduction.

Tranexamic acid: A synthetic lysine analogue that inhibits plasminogen activation and downregulates melanin synthesis in the epidermis.

Orbicularis oculi muscle: Circular muscle around the eye responsible for eyelid movement, targeted by electrical stimulation to improve periocular circulation and skin tone.

References

1. Optical characteristics of the skin with dark circles using pump-probe imaging. Scientific Reports (2022).
2. Effectiveness, safety, and patient satisfaction of carboxytherapy as an adjunctive treatment for periorbital hyperpigmentation. Skin Research and Technology (2024).
3. Comparison of the Effectiveness of Platelet‐Rich Plasma Versus Tranexamic Acid Plus Vitamin C Mesotherapy in the Treatment of Periorbital Hyperpigmentation: A Split‐Site, Randomized Clinical Trial. Journal of Cosmetic Dermatology (2024).
4. Electrical stimulation of the lower eyelid orbicularis oculi muscle improves periocular dark circles. Skin Research and Technology (2024).